Additional research is required to fully elucidate the novel relationship between TDAG51 and its downstream target TGF-β receptor 1, which will aid in discerning the specific mechanisms responsible for the development and progression of renal interstitial fibrosis in CKD. Here, PHLDA1 is linked to chronic kidney disease.